Atypical Hemolytic Uremic Syndrome in the Setting of Complement-Amplifying Conditions: Case Reports and a Review of the Evidence for Treatment With Eculizumab

Journal of Nephrology - United States
doi 10.1007/s40620-016-0357-7
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Eculizumab in Atypical Hemolytic–Uremic Syndrome

New England Journal of Medicine
Medicine
2013English

Prophylactic Eculizumab Use in Kidney Transplantation: A Review of the Literature and Report of a Case With Atypical Hemolytic Uremic Syndrome

Annals of Transplantation
MedicineTransplantation
2015English

Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome

Kidney International Reports
Nephrology
2019English

Resolution of Ocular Involvement With Systemic Eculizumab Therapy in Atypical Hemolytic-Uremic Syndrome

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2013English

The Development of Atypical Hemolytic Uremic Syndrome Depends on Complement C5

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2010English

Atypical Hemolytic Uremic Syndrome: A Case Report

Cureus
2019English

The Genetics of Atypical Hemolytic Uremic Syndrome

Medizinische Genetik
Genetics
2018English

Atypical Hemolytic-Uremic Syndrome

2020English

Optimal Duration of Treatment With Eculizumab in Atypical Hemolytic Uremic Syndrome (aHUS)—a Question to Be Addressed in a Scientific Way

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy